Bradáčová, P.; Slavík, L.; Úlehlová, J.; Kriegová, E.; Jará, E.; Bultasová, L.; Friedecký, D.; Ullrychová, J.; Procházková, J.; Hluší, A.;
et al. Determining Thrombogenicity: Using a Modified Thrombin Generation Assay to Detect the Level of Thrombotic Event Risk in Lupus Anticoagulant-Positive Patients. Biomedicines 2023, 11, 3329.
https://doi.org/10.3390/biomedicines11123329
AMA Style
Bradáčová P, Slavík L, Úlehlová J, Kriegová E, Jará E, Bultasová L, Friedecký D, Ullrychová J, Procházková J, Hluší A,
et al. Determining Thrombogenicity: Using a Modified Thrombin Generation Assay to Detect the Level of Thrombotic Event Risk in Lupus Anticoagulant-Positive Patients. Biomedicines. 2023; 11(12):3329.
https://doi.org/10.3390/biomedicines11123329
Chicago/Turabian Style
Bradáčová, Pavla, Luděk Slavík, Jana Úlehlová, Eva Kriegová, Eliška Jará, Lenka Bultasová, David Friedecký, Jana Ullrychová, Jana Procházková, Antonín Hluší,
and et al. 2023. "Determining Thrombogenicity: Using a Modified Thrombin Generation Assay to Detect the Level of Thrombotic Event Risk in Lupus Anticoagulant-Positive Patients" Biomedicines 11, no. 12: 3329.
https://doi.org/10.3390/biomedicines11123329
APA Style
Bradáčová, P., Slavík, L., Úlehlová, J., Kriegová, E., Jará, E., Bultasová, L., Friedecký, D., Ullrychová, J., Procházková, J., Hluší, A., Manukyan, G., & Štefaničková, L.
(2023). Determining Thrombogenicity: Using a Modified Thrombin Generation Assay to Detect the Level of Thrombotic Event Risk in Lupus Anticoagulant-Positive Patients. Biomedicines, 11(12), 3329.
https://doi.org/10.3390/biomedicines11123329
